Chemistry, Pharmacology, and Clinical Efficacy of the Chinese Nootropic Agent Huperzine A
- 1 May 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 32 (8), 641-650
- https://doi.org/10.1021/ar9800892
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Effects of Metrifonate on Cognitive Decline in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1998
- Efficacy of huperzine in preventing soman‐induced seizures, neuropathological changes and lethalityFundamental & Clinical Pharmacology, 1997
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997
- Rationale and Design of a Multicenter Study of Selegiline and α-Tocopherol in the Treatment of Alzheimer Disease Using Novel Clinical OutcomesAlzheimer Disease & Associated Disorders, 1996
- Physiological production of the β-amyloid protein and the mechanism of Alzheimer's diseaseTrends in Neurosciences, 1993
- Mechanism of inhibition of cholinesterases by huperzine ABiochemical and Biophysical Research Communications, 1992
- Reaction of aminopropanedinitrile 4-methylbenzenesulfonate (aminomalononitrile p-toluenesulfonate (tosylate)) with isothiocyanatesThe Journal of Organic Chemistry, 1991
- Reactions of the (.eta.3-allyl)iron tricarbonyl anion with carbon electrophilesJournal of the American Chemical Society, 1989
- The silent epidemic: the search for treatment of age-related memory impairmentTrends in Pharmacological Sciences, 1989
- Progress in the synthesis of polycyclic natural products: The total synthesis of lycopodinePublished by Walter de Gruyter GmbH ,1968